Pharma Focus Asia

KD Pharma Group invests in Nutriceutical Holdings

Friday, June 02, 2017

Nutriceutical Holdings (NH), parent company of Physician Recommended Nutriceuticals (PRN) and Veterinarian Recommended Solutions (VRS), and KD Pharma Group have decided to join forces through a direct investment in Nutriceutical Holdings by KD Pharma Group. KD Pharma Group will become the largest shareholder in Nutriceutical Holdings with the option to acquire the entire company.

"We believe we have found the ideal partner in KD. They are committed to growing the NH companies by providing us with supply chain certainty and superior Omega-3 manufacturing technology that can help us excel within a competitive Omega-3 landscape," said PRN CEO, Ken Krieg. "We are pleased to have a capital partner that shares our vision for growing PRN and VRS."

"We are extremely excited to be partnering with a fast-growing company that shares our passion for product excellence," says KD Pharma CEO, Oscar Groet.  "The investment in NH gives KD growth opportunities in two rapidly growing markets for Omega 3, eye and animal health."

magazine-slider-image
magazine-slider-image
Cytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024